All News
STAT+: Reeling from Trump contract cuts, the National Academies prepares for ‘a fairly radical downsizing’
Nation's leading advisory body on issues of science and technology is "preparing for a fairly radical downsizing.
Read MoreKFF Health News' 'What the Health?': Bill With Billions in Health Program Cuts Passes House
The House narrowly passed a budget reconciliation bill, including billions of dollars in tax cuts for the wealthy along with billions of dollars in cuts to health program spending.
Read MoreRecent Developments in Bladder Cancer
(MedPage Today) -- From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments in bladder cancer frequently have made news over the p
Read MoreFFRangio Makes a Strong Impression as Wannabe FFR Alternative
(MedPage Today) -- A randomized trial laid the groundwork for FFRangio, a proprietary angiography-derived fractional flow reserve (FFR) tool, as a potential gatekeeper for coronary revascularization.
Read MoreBilly Joel Announces Brain Disorder and Cancels All Concerts
Joel said he had normal pressure hydrocephalus, which has led to “problems with hearing, vision and balance.
Read MoreFDA Approves Mepolizumab for COPD
(MedPage Today) -- The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday.
Read MoreFunding for 988 Crisis Line Holding Steady for Now
(MedPage Today) -- With all of the healthcare funding cuts currently going on in Washington, there is one health service that has survived mostly unscathed -- the 988 Suicide and Crisis Lifeline.
Read MoreKnow the dangers of 'orthotropics' | Letter
Prof Grant McIntyre responds to an article on ‘orthotropics’ and its proponent Dr Mike TewI would like to thank the Guardian for highlighting the dangers of “orthotropics” in its interview wit
Read MoreNiraparib Shows Mixed Signals in Early Prostate Cancer Treatment
(MedPage Today) -- At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new
Read MoreMedPod Today: Alzheimer's Blood Test; Vax Claims Debunked; Top GLP-1 for Weight Loss
(MedPage Today) -- The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody.
Read More